|
Quotes & Info
|
| OME > SEC Filings for OME > Form 8-K on 7-Dec-2012 | All Recent SEC Filings |
7-Dec-2012
Change in Directors or Principal Officers, Financial Statements and Exhibits
On December 4, 2012, the Compensation Committee of the Board of Directors of Omega Protein Corporation (the "Company") awarded the following grants of restricted common stock under the Company's 2006 Incentive Plan to the Company executive officers listed below:
Officer Title Number of Shares
Bret D. Scholtes President and Chief Executive 50,000
Officer
Andrew C. Johannesen Executive Vice President and 35,000
Chief Financial Officer
John D. Held Executive Vice President, 25,000
General Counsel and Secretary
Dr. Mark E. Griffin Senior Vice President - Sales 35,000
and Marketing and R & D
Matthew Phillips President of Cyvex Nutrition, 25,000
Inc. subsidiary
Gregory Toups Vice President, Controller and 10,000
Chief Accounting Officer
|
All of these shares will vest on December 4, 2015 and have a value of $6.31 per share, the Fair Market Value (as defined in the 2006 Incentive Plan) on the date of grant. The grants were made pursuant to the form of Restricted Stock Agreement attached hereto as Exhibit 10.1.
The foregoing description of the Restricted Stock Agreement does not purport to be complete and is qualified in its entirety by reference to the form of Restricted Stock Agreement, which is attached as Exhibit 10.1 hereto and incorporated herein by reference.
On December 4, 2012, the Compensation Committee also approved the following discretionary cash bonuses to be paid to the Company executive officers listed below:
Officer Title 2012 Cash Bonus
Bret D. Scholtes President and Chief Executive $270,000
Officer
Andrew C. Johannesen Executive Vice President and Chief $195,000
Financial Officer
John D. Held Executive Vice President, General $175,000
Counsel and Secretary
Dr. Mark E. Griffin Senior Vice President - Sales and $190,000
Marketing and R & D
Gregory Toups Vice President, Controller and $90,000
Chief Accounting Officer
|
(d) Exhibits
10.1 Form of Restricted Stock Agreement dated as of December 4, 2012.
|
|